Until 2020, two lineages of the influenza B virus had co-circulated globally. Measures to control the COVID-19 pandemic led to a near-absence of influenza infections. While B/Victoria reemerged in late 2021, there have been no reports of B/Yamagata since the pandemic. To investigate which epidemiological and immunological factors were primarily responsible for the extinction of B/Yamagata, we developed a global model for the two influenza B lineages. To mimic the transmission impacts of the pandemic, we implemented a transient reduction in contacts and identified parameter values that recapitulated viral coexistence dynamic before the pandemic and the qualitative post-pandemic outcomes of B/Victoria (reemergence in late 2021) and B/Yamagata (extinction). Our results suggest that, rather than immunological or evolutionary mechanisms, the extinction of B/Yamagata was mainly driven by its lower basic reproduction number making the virus particularly vulnerable during the early phase of the pandemic. Stochastic simulations of our best-fitting model suggest that B/Victoria was also close to extinction during this period. We investigate the model to assess the feasibility of B/Victoria eradication through vaccination and the potential for a sustained re-emergence of B/Yamagata in the 2026-27 flu season, thus highlighting important considerations for biosafety. For decades, the Yamagata and Victoria lineages of the influenza B virus co-circulated globally, causing millions of infections in humans. Only Victoria reemerged after the COVID-19 pandemic. By combining mechanistic transmission modeling with worldwide influenza surveillance data, we show that Yamagata's extinction is most consistent with a lower intrinsic transmissibility than that of the surviving Victoria lineage. Contrary to other proposed explanations, differences in cross-immunity and immune escape appear insufficient to explain the observed outcome. Our analyses further indicate that Victoria narrowly avoided extinction during the COVID-19 disruption, but now transmission of Yamagata would be sustained if the lineage were reintroduced. These results inform both influenza eradication efforts and biosafety policy.
Neonatal mortality remains disproportionately high in sub-Saharan Africa, where an estimated 27 neonatal deaths per 1,000 live births occur annually. Infections, including sepsis and meningitis, account for a substantial proportion of these deaths, while neural tube defects (NTDs) contribute significantly to both neonatal mortality and long-term disability. Existing surveillance systems in the region are predominantly facility-based, missing the substantial proportion of births and deaths that occur in the community. Population-based surveillance platforms that capture community-level data are urgently needed to generate accurate incidence estimates, identify modifiable risk factors, and guide evidence-based interventions. The Consortium to Reduce Infant Mortality (CONRIM) is a multi-institutional partnership among Ugandan physicians and scientists, Yale University, Penn State University, Boston Children's Hospital/Harvard Medical School, and Uganda's National Planning Authority. CONRIM conducts prospective, community-based neonatal surveillance within the Busoga Kingdom in eastern Uganda. A network of 813 trained Village Health Team members conducts household-level visits using a structured Open Data Kit (ODK)-based mobile questionnaire to capture every birth, assess for danger signs of possible serious bacterial infection (pSBI), screen for NTDs, and record maternal nutrition and folic acid use, water, sanitation and hygiene (WASH) conditions, and health care utilization. Since surveillance began in June 2025, the platform has registered approximately 22,200 household submissions and over 5,700 newborn encounters across the Jinja District (population 660,000). Early data have identified higher than expected rates of infants with NTDs including encephalocele and spina bifida; documented folic acid non-use in before and during most pregnancies; characterized WASH conditions in birthplaces; and mapped geospatial hotspots of neonatal infection risk in northeastern rural subcounties. Prospective 28-day follow-up of all live births has demonstrated a neonatal mortality rate of 21.5 per 1000 live births. A real-time data quality monitoring system with 21 automated quality control flags maintains a 99% clean-record rate. Ongoing and planned activities include laboratory-based confirmation of neonatal sepsis via blood culture and cerebrospinal fluid analysis with polymerase chain reaction capacity, portable neuroimaging for NTDs, environmental sampling, genomic studies of folate metabolism pathway genes, linkage with facility-based records at Jinja Regional Referral Hospital and Mulago National Referral Hospital, and community-level interventions informed by surveillance findings. What is already known on this topic: Neonatal mortality remains disproportionately high in sub-Saharan Africa, with sepsis and neural tube defects (NTDs) among the leading preventable causes. Existing surveillance systems are predominantly facility-based and fail to capture births, deaths, and environmental exposures occurring at the community level. Emerging approaches in digital health, geospatial analytics, and pathogen genomics have demonstrated potential to enhance infectious disease surveillance, but these have rarely been integrated into population-based neonatal monitoring systems in low-resource settings.What this study adds: The Consortium to Reduce Infant Mortality (CONRIM) is a multidisciplinary initiative designed to develop scalable, population-based systems for understanding and reducing neonatal mortality through integrated epidemiologic, environmental, and biologic data. This paper describes one implementation of the CONRIM framework in the Busoga Kingdom of eastern Uganda, where a network of 813 trained Village Health Team members conducts longitudinal, community-based surveillance of births, neonatal outcomes, NTDs, maternal nutrition (including folic acid use), water, sanitation and hygiene (WASH) conditions, and care-seeking behaviour. This implementation integrates: real-time digital data capture with automated quality control,geospatial information systems (GIS) and remote sensing to characterize environmental risk factors,population-level genomic and metagenomic sampling to investigate host and pathogen factors, anda One Health framework linking human, animal, and environmental exposures. Early findings highlight high data completeness, geospatial clustering of neonatal infection risk, low preconception folic acid use, and identification of NTD cases not captured by facility-based systems.How this study might affect research, practice, or policy: This study demonstrates the feasibility of implementing a community-based, real-time neonatal surveillance system within an existing community health worker network in a low-resource setting. By integrating geospatial, genomic, and environmental data within a unified platform, the CONRIM framework enables more precise identification of drivers of neonatal morbidity and mortality.The approach supports targeted public health interventions, including geographically informed infection control strategies, improved referral pathways, and evidence generation for folic acid fortification policies. More broadly, CONRIM provides a scalable infrastructure for future interventional studies and precision public health strategies aimed at reducing neonatal mortality.
Youth with HIV experience persistent disparities across the HIV care continuum, including low rates of engagement in care and viral suppression. In a recent national survey, youth and young adults, defined by the CDC as ages 13-34, accounted for approximately 20- 40% of new HIV diagnoses in the United States. We describe the Intervention for Virological Suppression in Youth with HIV (iVY), a youth-friendly, tailored approach that integrates mental health and substance use support with HIV treatment engagement. This paper describes the development of the intervention used in iVY, which is currently being evaluated in a randomized clinical trial (RCT) using an adaptive treatment strategy. HIV virological suppression is measured via dried blood spot at 16 weeks. The intervention is delivered fully remotely across California and Florida. YWH aged 18-29 who are not durably virally suppressed are enrolled and randomized to the intervention or usual care. The RCT will enroll and randomize 200 participants to the intervention ( n = 100) versus usual care ( n = 100). iVY includes: (1) tailored brief, weekly video-counseling sessions focused on HIV treatment adherence and engagement, mental health, substance use, and related barriers; and (2) a mobile health application designed to support adherence, resource access, and peer connection. Participants who are not virally suppressed receive an additional 16 weeks of intensified intervention, while responders continue with app-based support. N/A. This paper provides a detailed description of a telehealth-based behavioral intervention tailored to the needs of youth with HIV. The intervention offers a scalable model for integrating behavioral health and HIV care to address barriers to treatment engagement in this priority population.
Clinical decision support (CDS) systems can improve care quality, but their implications for equity remain uncertain. We examined whether provider response to CDS alerts differed by patient race and sex in primary care, and whether differences in alert exposure helped explain any observed variation. We conducted a retrospective study using EHR data from a New York City academic health system, focusing on alert-based CDS during outpatient primary care. Logistic regression was used to estimate the likelihood of alert engagement by patient race and sex, while adjusting for encounter and provider factors. We used a generalized structural equation model to assess mediation by alert type, decomposing direct and indirect effects of demographics on response.Direct effects suggest that providers may respond differently to alerts based on patient identity, consistent with interpersonal bias, in which implicit or explicit attitudes shape clinical behavior, and on the context of the visit. Indirect effects highlight disparities in how alerts are assigned across groups, indicating that algorithmic or systemic bias may be embedded within the technology itself. Estimated mediated pathways suggest that even when providers respond uniformly to alerts, unequal exposure can still produce inequitable outcomes. The findings highlight that the type of CDS triggered plays a significant role in differential CDS responses, with provider- and patient-related factors evident in these differences. These findings underscore the need to evaluate not only provider behavior but also the logic and distribution of CDS tools themselves, as both can contribute to disparities in care delivery. Further research should also focus on looking for the potential health impact of the differential response. Digital tools meant to standardize care can unintentionally contribute to which patients receiving care. We investigate whether providers' use of these tools is related to a patient's identity or influenced by the types of tools provided to them in primary care. Using electronic health record data from a large urban health system, we find that providers' responses to alerts are shaped not only by patient identity but also by the nature of the alert itself. Direct effects suggest that providers may engage differently with CDS based on patient demographics, indicating potential interpersonal bias. Indirect effects reveal that certain patient groups are more or less likely to receive specific types of alerts, indicating embedded algorithmic or systemic bias. These findings underscore the importance of evaluating both provider behavior and the design of CDS tools when assessing equity in digital health. Even when providers respond consistently, unequal exposure to alerts can produce inequitable outcomes. Our results underscore the need for more transparent and equity-aware CDS design and implementation strategies that consider both human and technological sources of bias.
Behavioral crises are common and distressing in children with neurodevelopmental or behavioral conditions, and many escalate to emergency service use. Access to behavioral therapy is often constrained. Smartphone applications, in-home systems, and wearable sensors that could support caregivers during crises at home are in active development, but few studies have asked caregivers what they would accept or want from such tools. We conducted a single-center cross-sectional online survey (REDCap) of caregivers of children aged 5-17 years with neurodevelopmental or behavioral conditions, recruited as a convenience sample through flyers, email invitations, and in-person invitations during clinic visits from the neurobehavioral continuum of care at Cincinnati Children's Hospital Medical Center. The response rate is undetermined due to the open-ended recruitment process. Prior behavioral-crisis experience was not an eligibility requirement. The 24-item instrument covered crisis burden, service utilization, caregiver confidence and training, therapy access and barriers, and technology preferences. Analyses were estimation-first (proportions with Wilson 95% confidence intervals [CIs]; medians with interquartile ranges [IQRs]); three pre-specified bivariate analyses used ordinal methods (Kendall's tau-b and Jonckheere-Terpstra for ordinal pairs; Friedman for repeated ratings of five support functions). Recruitment closed on July 22, 2026 with 84 respondents (one additional study-team test entry was excluded), exceeding the feasibility-based enrollment target of 75; this full-sample analysis supersedes the interim analysis of the first 55 respondents posted as version 1 of this preprint, and all findings remain hypothesis-generating. Seventy-eight of 84 responding caregivers (93%; 95% CI 85-97%) reported that their child had ever experienced a behavioral crisis; 43% (95% CI 33-54%) reported crises at least weekly, and 27% (95% CI 19-38%) had ever used 911 or an emergency department for a crisis. Half of caregivers (52%) felt not at all or only a little confident managing crises, and fewer than half (48%; 95% CI 37-58%) had received informal or formal crisis-management training. The most frequent barrier to behavioral therapy was long waitlists (57%; 95% CI 46-67%). Stated openness to hypothetical technology-based crisis support was high, with 60% (95% CI 49-69%) very interested in a smartphone app or in-home support system, 81% (95% CI 71-88%) willing to have their child use a wearable sensor (1 of 84 declined), and 49% (95% CI 39-60%) willing to share video or audio with a future support tool (a further 43% answered "maybe"; 7% declined). The most-valued features were a personalized crisis plan (63%) and safe de-escalation scripts (46%); the most-cited concern was privacy and data security (38%). In this self-selected, single-center sample, caregivers of children with neurodevelopmental or behavioral conditions reported substantial crisis burden, limited training, and constrained access to therapy, alongside high stated openness to technology-based crisis support; personalization and privacy were their leading priorities. These preliminary, hypothesis-generating findings can inform the design of caregiver-facing crisis-support technologies and larger representative studies.
The Diabetes Prevention Program (DPP) was a randomized clinical trial designed to prevent type 2 diabetes (T2D) in adults with prediabetes. The DPP Outcomes Study (DPPOS) is the 30-year follow-up of this cohort, focusing on T2D, prediabetes, and related complications. Cognitive assessments began in 2009 and expanded in 2022 to examine cognitive impairment, including Alzheimer's disease (AD) and AD related dementias (ADRD), in the surviving cohort. To support these aims, the National Alzheimer's Coordinating Center Uniform Data Set version 3 (NACC-UDSv3), the standardized framework used by Alzheimer's Disease Research Centers, was implemented in DPPOS in 2022 to enable data sharing with NACC. These forms were complemented by cognitive tests administered in DPPOS. We aimed to integrate the NACC-UDSv3 into the existing longitudinal DPPOS framework while maintaining fidelity to its structure and developing automated reports to streamline cognitive outcomes adjudication. Items from the 16 NACC-UDSv3 data forms were compared with those already collected within DPPOS to integrate overlapping similar items, add missing NACC-UDSv3 items, and create a dataset harmonized with NACC-UDSv3. Forms were adapted for electronic data capture (EDC) using the MIDAS (Multimodal Integrated Data Acquisition System, George Washington University). Automated reports integrated current and prior neuropsychological scores to support adjudications. In the first wave of the DPPOS-AD/ADRD study, 1561 cognitive adjudications were successfully completed using the harmonized DPPOS and NACC-UDSv3 data implemented into MIDAS. The DPPOS-AD/ADRD project demonstrated that NACC-UDSv3 can be successfully integrated into a long-standing longitudinal cohort not originally designed for AD/ADRD research. The harmonization, electronic capture, and automated adjudication processes may provide a practical framework for other cohorts seeking to incorporate NACC-UDSv3 to align with national AD/ADRD research standards.
Real-time forecasts of seasonal respiratory outbreaks are critical for public health preparedness and healthcare planning. Multi-model ensembles, which combine predictions from individual models, have become a leading approach for operational outbreak forecasting. Their success, however, depends in part on the assumption that component models make sufficiently independent errors. Here, we examined this assumption using archived real-time forecasts for influenza hospitalizations and influenza-like illness (ILI) in the United States. We found that component models with diverse structures and calibration methods shared systematic forecast errors during epidemic growth and around epidemic peaks, reflecting the common challenge of tracking rapid changes in epidemic dynamics from real-time surveillance data. Because such shared errors cannot be fully corrected by ensembling alone, we developed a deep learning framework that learns structured residual errors from historical forecasts and uses them to correct ensemble predictions. This framework improved influenza hospitalization forecasts across horizons and geographic scales, reducing the Weighted Interval Score by up to 20% at the national level and 12% across states relative to official ensemble forecasts, with the largest improvements at the near-term horizon and during epidemic growth and peak periods. We further showed that learned residual structures transferred across ensembles formed from different component models, making the approach robust to changes in model participation across seasons. The framework also improved ensemble forecasts for ILI, although gains were more modest. These findings reveal a fundamental challenge in ensemble forecasting and provide a generalizable approach for improving real-time epidemic forecasts.
Working memory (WM) deficits are a co-occurring feature to numerous neuropsychiatric disorders, particularly attention- deficit/hyperactivity disorder (ADHD), and there remain no treatments that directly target WM. The coupling between the phase of theta band activity and amplitude of gamma band activity (i.e., TGC) is an established neural correlate of WM. However, no studies have examined WM-related TGC in ADHD or whether neuromodulation can modulate these oscillatory dynamics in youth. This set of studies examined the effects of intermittent theta burst stimulation (iTBS) to the left dorsolateral prefrontal cortex (DLPFC) and left posterior parietal cortex (PPC) on TGC in youth with ADHD. In two randomized, double-blind, sham-controlled crossover trials, adolescents with ADHD and clinically significant parent-reported WM symptoms first completed a single-session study comparing DLPFC versus PPC iTBS targeting (n = 47) and then a multi-session clinical trial comparing 10 sessions of active versus sham left DLPFC iTBS (n = 29). Participants completed a computerized visuospatial Sternberg WM task with concurrent electroencephalography (EEG) before and after the single sessions, as well as at baseline, midway through treatment, and approximately 24 hours after the final session within the multi-session trial. Phase-amplitude coupling between theta phase and gamma amplitude was quantified using the Kullback-Leibler modulation index at frontoparietal electrodes. Linear mixed-effects models examined treatment effects and associations between change in TGC and WM status (including accuracy, reaction time, and clinical symptoms). Across participants, lower TGC was associated with lower symptoms and better WM performance, including higher accuracy, faster and more consistent RT. Active iTBS increased frontoparietal TGC relative to sham stimulation, with effects observed both acutely after a single session and ∼24 hours after multiple sessions. DLPFC-targeted iTBS increased TGC, whereas PPC-iTBS had no measurable effect. Change in TGC was associated with change in WM, such that a decrease in TGC was associated with faster RT and decreased RT variability. Higher baseline TGC was associated with greater improvement in WM. Active iTBS decoupled the TGC-WM association observed during sham iTBS, and greater electric field intensity of iTBS was associated with greater improvement in WM accuracy and greater decrease in TGC. Active iTBS to the left DLPFC modulated WM-related TGC in youth with ADHD. These findings provide preliminary evidence that neuromodulation may improve WW by modifying oscillatory dynamics within frontoparietal networks. Larger clinical trials with higher stimulation doses are needed to determine whether targeting oscillatory coupling represents a potential therapeutic strategy for WM deficits. Trial Registrations: NCT05102864 ; NCT05662280.
Behavioral intervention studies for family care partners for those with dementia need to be both feasible and acceptable in order implement and complete the investigative work. Our study, Tele-STELLA (Support via Technology: Living and Learning with Advancing dementia), was as single arm clinical trial completed in 2025. While 188 care partners enrolled, the attrition rate was high (44%). Here we describe the feasibility, acceptability, fidelity processes and preliminary efficacy of Tele-STELLA. Quantitative measures were used to assess care partner burden, study participation, feasibility and acceptability. Our weekly survey assessed the prevalence of adverse events. Qualitative methods paralleled our quantitative findings, in that care partners generally found the study acceptable, but dementia progression and life demands made participation difficult for some. The total attrition rate was 44% but was attenuated by increasing the sample size. This adequately-powered study found that the intervention significantly reduced burden. Overall, care partners found the study feasible, but care demands made participation difficult for 28 of the care partners resulting in their withdrawal. In addition, 21 care recipients died, and thus their care partners had to be removed from the study. Protocol deviations and losing care partner contact also added to the attrition rate. Our findings reveal that, even in the later stages of dementia, care partners are willing to participate in intervention research. However, care demands and death can affect the sample size. Our data and recommendations for future studies will inform caregiving scientists in designing behavioral interventions in late-stage dementia.
Metallic implants such as orthopedic screws, prostheses, and dental hardware produce beam-hardening, photon-starvation, and streak artifacts that degrade computed tomography (CT) image quality, and the metal artifact reduction (MAR) methods developed to mitigate them require objective, reproducible benchmarking. Objective evaluation of MAR algorithms in CT is hindered by the absence of phantoms that simultaneously provide anatomically realistic backgrounds, embedded implants of known geometry, and controllable, ground-truth-referenced artifact intensity. We present a dual-filament, voxel-level three-dimensional (3D) printing method that fulfills these requirements and demonstrate its capabilities on a clinically representative cervical spine case with embedded orthopedic spinal screws. The proposed method extends the PixelPrint framework, a fused-deposition-modeling (FDM) workflow that converts clinical Digital Imaging and Communications in Medicine (DICOM) data directly into 3D-printer Geometric code (G-code) without intermediate segmentation or surface meshing, to interleaved, voxel-level deposition of two filaments: a calcium-doped polylactic acid (PLA) for soft tissue and bone, and a higher-attenuation metal-doped PLA for metallic implants. For demonstration, anonymized DICOM data of a healthy cervical spine were used to design and fabricate three matched phantoms, each with six embedded spinal screws at C4-C6: a 0% metal-infill ground-truth phantom, a 50% medium-metal-infill phantom, and an 85% high-metal-infill phantom. All phantoms were scanned on a clinical spectral CT system at 120 kVp and 1000 mAs, reconstructed at 0.67 mm slice thickness with virtual monoenergetic imaging (VMI) across 50-190 keV. Method performance was characterized by region of interest (ROI)-based Hounsfield Unit (HU) agreement with the source patient data and by the noise-independent Gumbel-distribution p-index metric. The dual-filament method reproduced patient anatomy, soft-tissue contrast, and screw geometry with high fidelity. ROI HU values agreed with patient data within ±25 HU for soft tissue and trabecular bone; cortical regions were underestimated owing to the current ceiling of the calcium-doped PLA used in this study. The tunable-artifact behavior was quantified as follows: the Gumbel location parameter μ scaled monotonically from 46.7 HU (no-metal background) to 57.1 HU (50% infill) to 90.5 HU (85% infill) for the VMI 70 keV with standard filter. High-keV VMI reconstructions substantially reduced streak and beam-hardening artifacts while preserving anatomic detail. The proposed dual-filament, voxel-level PixelPrint method enables the fabrication of patient-specific, multi-material CT phantoms with embedded metallic implants and controllable, ground-truth-referenced artifact intensity. Although demonstrated here in a single cervical-spine case, the workflow is anatomy- and implant-agnostic by construction and could in principle be adapted to other musculoskeletal sites (e.g., knee, hip, dental) and implant materials, providing a reproducible methodological foundation for benchmarking MAR algorithms, characterizing spectral CT performance, and validating emerging photon-counting detector systems.
Palliative care is recommended by clinical practice guidelines for patients with advanced heart failure (aHF), yet specialty palliative care (SPC) remains substantially underutilized in this population. We sought to quantify between-facility variation in SPC receipt among people with aHF and determine how much variation is explained by patient case mix and facility structural characteristics versus residual unmeasured factors. This retrospective cohort study included 23,991 Veterans with prevalent aHF identified through administrative data across 133 VA Medical Centers (VAMCs) with ≥20 aHF cases, from January 2022 to December 2023. Variation was assessed using multilevel logistic regression with facility random intercepts, the intraclass correlation coefficient (ICC), and the adjusted median odds ratio (aMOR). Facility-specific risk-standardized SPC rates were used to estimate SPC encounters attributable to facility performance better or worse than the national rate. Of the sample, the mean patient age was 72.3 years (SD = 10.0), and 97.6% were male. The national observed rate of SPC was 17.5%, with risk-adjusted rates varying approximately 14-fold across facilities (3.3% to 45.6%). The adjusted ICC was 11.5%, and aMOR was 1.87 (95% Confidence Intervals 1.70-2.06). Measured patient case-mix and facility structural characteristics explained only 18.9% of between-facility variation (proportional reduction in the ICC, fully adjusted vs. null model). Facilities performing better than the national rate delivered 791 more SPC encounters than expected (17.8%), while those performing worse than the national rate delivered 480 fewer encounters than expected (10.8%). In the context of a national mean rate of SPC that reflects substantial underuse, delivery varied 14-fold across VAMCs, with most variation unexplained by patient complexity or measured facility resources. These findings suggest that potentially modifiable organizational factors, beyond patient preferences or facility structures alone, may contribute to current utilization gaps and represent actionable targets for quality improvement. What is new?: In this national cohort of 23,991 people with advanced heart failure cared for at 133 VA Medical Centers, risk-adjusted rates of specialist palliative care delivery varied 14-fold across facilities (median odds ratio 1.87). Measured patient case-mix and facility structural characteristics explained only 18.9% of the between-facility variation.Clinical implications?: Substantial variation in palliative care delivery across VAMCs is not accounted for by differences in patient complexity or facility resources, suggesting that institutional processes and referral practices are key drivers and represent actionable targets for quality improvement.
Clinical decisions for determining optimal patient-specific interventions are complicated prediction tasks that rely on health care professionals' understanding of physiological mechanisms and their dynamics. These decisions are challenged by (a) observational data sparsity and (b) patient heterogeneity. Here, we focus on estimating and forecasting specific physiological properties-that are not explicitly present in clinical observations-to provide additional features using only data available bedside at the time of decision-making. Mechanistic models of physiological system(s), e.g., physiological ordinary differential equation (ODE) models, provide pathways to compensate for data sparsity by synchronizing the model with observations of an individual patient using data assimilation (DA). However, DA used in a standard computational workflow to estimate constant model parameters from presently-known data is less effective at optimizing state forecasts of the model governed by physiological processes that evolve before new observations are available. Stated simply, we cannot forecast the future evolution of the model because we cannot forecast model parameters. To support next-generation clinical decision support, we develop a new DA and machine learning (ML) hybrid pipeline to estimate and forecast individual future physiological processes by forecasting ODE model parameters. This pipeline overcomes model and DA workflow limitations by stacking a DA-estimated posterior empirical distribution of physiological parameters with longitudinal ML forecasting models. We work within the context of glycemic management in an ICU using EHR data to construct and test a use case. We use synthetic data and real-world clinical data to validate the integrated pipeline and quantify uncertainties.
CAG repeat expansions in ATXN2 are implicated as risk factors for several neurological diseases, including spinocerebellar ataxia type 2 (SCA2) when >=33 CAG repeats are present, and amyotrophic lateral sclerosis (ALS) when 27-33 CAG repeats are present. However, how haplotypes around the repeats and CAA interruptions within the repeats are associated with disease phenotypes remains poorly understood. Previous studies on haplotypes around ATXN2 were limited to SNPs very close to the repeats (<5kb) or were based on statistical inference only. Here, we used long-read sequencing on the Oxford Nanopore Technologies (ONT) platform to simultaneously infer haplotypes around ATXN2 , the number of CAG repeats, and the number of CAA interruptions, along with NYGC ALS Consortium NGS dataset. We further sequenced 41 individuals (EUR = 39) with neurological diseases with intermediate repeats by ONT. We found that haplotypes around ATXN2 and the number of interruptions show ethnicity-specific and ALS-specific distribution. Three CAA interruptions are present at low prevalence (∼1%) in control populations in multiple ancestry groups, but high prevalence (∼55%) in ALS individuals with intermediate repeats. Furthermore, we examined 159 individuals with ALS (∼90% European ancestry) with intermediate ATXN2 repeats and found a unique haplotype in ALS individuals with three CAA interruptions, which can be tagged by an SNV, rs148019457. We also validated that the rs148019457-G allele is only present in haplotypes with three CAA interruptions. In summary, our study shows that 3 CAA interruptions are rarely seen in healthy controls but are common in those with expanded ATXN2 CAG repeats who have neurological disorders, and that rs148019457 tags a specific haplotype with 3 CAA interruptions within expanded ATXN2 CAG repeats in individuals of European ancestry. These results have implications for the development of precision genomic medicine for neurological disorders, and the tag SNP may help identify those with interruptions from existing population genotyping data.
Peripheral artery disease (PAD) is an occlusive arterial disease primarily affecting the lower extremities. It impacts over 230 million people worldwide and is associated with significant morbidity and mortality. The ankle brachial index (ABI) test is a non-invasive method to detect PAD that compares the blood pressure in the ankle and arm to evaluate lower extremity blood flow. An estimated 20-50% of individuals with detectable PAD are asymptomatic and remain undiagnosed; however, ABI screening in high-risk, asymptomatic populations is not currently guideline-recommended. Few studies have evaluated change in ABI over time in asymptomatic populations. Therefore, we aimed to identify distinct trajectories of ABI values from mid-to late-life. We utilized data from the Atherosclerosis Risk in Communities (ARIC) study; a longitudinal cohort study initiated in 1987 that enrolled 15,792 participants aged 45-64. ABI measurements were collected at five visits over a 30-year period. We used group-based trajectory modeling to identify trajectories of ABI from mid-to late-life. Final model selection was based on visual fit, statistical criteria, group sizes, and substantive knowledge. Lastly, we compared baseline demographics, social determinants of health, and overall cardiovascular (CV) health, assessed using the American Heart Association's Life's Essential 8 (LE8) framework, across trajectory groups. We identified 4,121 participants with ≥3 ABI measurements over the study period in at least one limb. At baseline, participants had an average age of 51.4 ± 4.9 years, were 57.3% female, 22.2% Black, and had an average overall LE8 score of 68.0 ± 13.9 points. Our final model identified three linear trajectories: low-normal, high-normal, and declining. Overall LE8 scores varied significantly across trajectory groups: 67.3 ± 10.7 (high-normal), 61.9 ± 13.3 (low-normal), and 50.1 ± 15.8 points (declining). Women had lower average ABI values, were more likely to experience a declining ABI trajectory, and had a delayed onset of decline compared to men. A greater proportion of Black participants experienced declining ABIs, with earlier, faster, and more severe declines than White participants. Poor overall CV health and common CV risk factors are associated with ABI decline. Targeted ABI screening in middle age may help detect PAD in its beginning stages and support early intervention.
Clostridioides difficile is the leading cause of healthcare acquired infections (HAIs). Healthcare systems lack scalable strategies to identify patients colonized with toxigenic strains to inform prevention programs. We developed a scalable program using rectal swabs, collected for vancomycin resistance Enterococci surveillance, with ex vivo amplification of C. difficile in Cdiff Banana Broth (BB). Optimized confirmatory testing of BB-positive tubes used the rapid C. difficile QuickCheck assay with Cepheid's Xpert® C. difficile/Epi (Xpert) to confirm toxin gene carriage for QuickCheck results of C. difficile glutamate dehydrogenase-positive (GDH) and antigenic toxin-negative. BB with confirmation demonstrated 92% specificity and 100% sensitivity, to a limit of <5 colony forming units (CFU)/swab, versus published values of 100/swab by ChromID® C. difficile agar and 460/swab by direct Xpert swab testing. The two-step confirmation detected toxigenic C. difficile in cases missed by other methods. Prospective testing of 797 VRE swabs from 538 ICU and inpatient oncology patients seen at an academic medical center and two community hospitals demonstrated 11% positivity for toxigenic and 4% for non-toxigenic C. difficile. Among swabs, 32% of toxigenic C. difficile were resulted at 24 hours and 68% at 48 hours. Addition of 17% glycerol to BB-positive aliquots, for -80°C storage, supported 100% retrieval of C. difficile 7 months later. BB with confirmation provides a more sensitive method to detect patient colonization with toxigenic C. difficile and, by using VRE surveillance swabs, does not require additional patient samples. The simplified approach can be deployed across healthcare settings to support C. difficile -prevention programs. C. difficile infections are the most prevalent HAIs, causing substantive mortality, morbidity, and economic burden. Among HAIs, C. difficile remains the one pathogen lacking scalable surveillance strategies for clinical microbiology labs. We present an optimized strategy to enable C . difficile surveillance testing across broad clinical settings to enable prevention programs for this pathogen.
This study aimed to examine patterns of deprescribing practices that are implemented after an emergency department (ED) visit due to antithrombotic-induced gastrointestinal (GI) bleeds among patients who concomitantly use antithrombotic and other medications. A retrospective cohort study design was used to identify a cohort of patients who visited an ED from the MarketScan® claims database (2016 - 2023). Concomitant use of antithrombotics and other medications was assessed in the 30 days prior to the ED date (index date). Those who presented with GI bleeds on their ED visit were classified as exposed vs those without GI bleeds (unexposed). Antithrombotic deprescribing - defined as discontinuation (≥45 days gap between refills), switching, or dose reduction - was assessed from the index date through to end of data. Inverse probability of treatment (IPT) - weighted logistic regression models were used to compare the odds of deprescribing between the exposed vs. unexposed groups. Of the 375,510 total concomitant users of antithrombotics and other agents, 9,145 had a GI bleed vs. not (366,365). The odds of antithrombotic deprescribing was significantly higher among the exposed vs unexposed, (odds ratio [OR], 1.39; 95% confidence interval [CI], 1.33, 1.46). There was no significant difference in the discontinuation of concomitant medications overall. However, among patients who continued antithrombotic use after the ED visit, the discontinuation of concomitant medications was relatively higher among the exposed (OR, 1.11; 95% CI, 1.05, 1.16). Antithrombotic agents were more likely to be deprescribed after an ED visit among patients who concomitantly used antithrombotics and other medications.
Transcranial magnetic stimulation (TMS) is widely used in both clinical and research settings to study and treat neurological and neuropsychiatric disorders, yet its underlying neural mechanisms remain unclear; particularly how stimulation influences both local and distant regional activity in relation to behavior. In this study, we combined single-pulse TMS with concurrent whole-head functional near-infrared spectroscopy (fNIRS) to examine hemodynamic and behavioral responses during a working memory task, with a focus on behavioral variability. Single TMS pulses were delivered to the left dorsolateral prefrontal cortex (DLPFC) while healthy participants rested; additionally, single pulses were delivered online to the left DLPFC while participants performed the working memory task. Across all participants, we observed a reliable load-dependent increase in hemodynamic activity associated with task. However, behavioral responses to TMS varied during the task. When participants were stratified into subgroups based on performance, a distinct topographic pattern emerged. During the task, TMS systematically modulated hemodynamic responses in regions including DLPFC, superior medial gyrus, precuneus, and parietal lobule, which are areas belonging to the default mode network. Moreover, the hemodynamic response during the single pulse alone sessions without any task was also found to be associated with the behavioral responses in a coherent pattern involving DLPFC, precuneus and parietal lobules. These findings suggest that variable behavioral outcomes during online TMS task are linked to distinct hemodynamic responses in a topographic pattern of local and distant regional areas.
The Dietary Approaches to Stop Hypertension (DASH) diet reduces blood pressure and cholesterol. However, the mechanisms underlying these effects are unclear, and no randomized studies have evaluated the long-term benefits on health outcomes such as coronary artery disease (CAD) or type 2 diabetes (T2D). We performed a series of Mendelian randomization analyses of 71 serum proteins perturbed by the DASH diet in previous randomized controlled feeding studies to understand their potential mechanistic role on health outcomes. Four proteins (ANGPTL3, INHBC, PCOLCE, PLXNB2) had causal evidence of beneficial effects on risk factors that aligned with diet-induced changes in protein levels. Missense variants in INHBC and PLXNB were associated with lower risks of CAD and T2D respectively, and these effects are directionally concordant with DASH diet-induced changes in protein levels, providing causal evidence that these proteins influence disease risk. Combining molecular phenotyping in randomized interventional studies with human genetics evidence identified molecular regulators of the long-term cardioprotective effects of the DASH diet.
Chemotherapy is a common treatment for women with ovarian cancer, and many women treated with chemotherapy experience cognitive dysfunction. However, few studies have investigated the mechanisms of chemotherapy-related cognitive impairment in women with ovarian cancer. The goal of this study was to assess the relationships among neurovascular coupling, iron levels and cognitive functions in women with ovarian cancer after first-line chemotherapy. Simultaneous fNIRS and EEG data were collected in women diagnosed with advanced stage ovarian cancer at baseline (N = 13) and after 3-9 rounds of chemotherapy (N = 8). The attentional network task (ANT) was administered for neurocognitive evaluation. Blood iron levels were measured using standard clinical assays. In parallel, similar concurrent fNIRS-EEG data were acquired in a group of 10 healthy participants in a test-retest design. Cognitive performance declined, as indicated by decreases in ANT sub scores after chemotherapy. Blood iron biomarkers indexing oxygen transport also declined and were related to decreases in the ANT sub scores. Both fNIRS and EEG data responses were shown to have excellent reliability in the healthy subjects, while cancer patients showed significant decreases in oxygenated hemoglobin response in fNIRS, despite no changes in EEG responses after chemotherapy. A significant dose relationship was also found in the changes of fNIRS responses. Our data indicate that chemotherapy produced cognitive deficits and decreases in the oxygenated hemoglobin response and that these may be related to reduced oxygen transport capacity. Results also suggest the utility of using fNIRS-EEG to monitor the progression of cognitive impairment and characterize those mechanisms.
The biomarker-based amyloid/ tau/ neurodegeneration (A/T/N) framework has become a popular staging method for Alzheimer's disease (AD) research. Previous studies use the framework either as a rule-based or data-driven approach but typically sacrifice either adaptivity or interpretability. We present an interpretable, hybrid method, called Neurosymodal Data Fusion, for predicting incident AD in the ADNI dataset. Specifically, we encode the A/T/N framework as a logic program, where the input biomarker features are extracted by one or more neural networks. Our pipeline predicted four-year incident AD with a sensitivity of up to 0.84. Additionally, our models learned scores for each A/T/N profile, denoting relative importances to model predictions. These scores also indicated that empirically-derived cut-off values for the A and T criteria might be uninformative for the ADNI data. Our pipeline provides a novel way to use the A/T/N framework that could potentially improve early AD screening years before clinical manifestations.